The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


ZANAFLEX

2 Base Milligrams Tablets

PCO ManufacturingPPA0465/168/001

Main Information

Trade NameZANAFLEX
Active SubstancesTIZANIDINE HYDROCHLORIDE
Strength2 Base Milligrams
Dosage FormTablets
Licence HolderPCO Manufacturing
Licence NumberPPA0465/168/001

Group Information

ATC CodeM03BX02 tizanidine

Status

Authorised/WithdrawnAuthorised
Licence Issued10/02/2006
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back